accountThe Food and Drug Administration has approved two three-month strengths of Abbott Laboratories’ Lupron Depot-PED to treat children with central precocious puberty.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to FDA OKs puberty drug treatment
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account